NCT01844999COMPLETEDanonymous

Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks

Sponsor

Source record

Dana-Farber Cancer Institute

Phase

Source record

Modality

AI-normalized

behavioral intervention

Target

AI-normalized

Personal Patient Profile - Prostate (P3P), Standard prostate cancer information websites

Indication / condition

AI-normalized

Prostate Cancer

Intervention

Source record

Personal Patient Profile - Prostate (P3P), Standard prostate cancer information websites

Source & freshness

Source record

NCT ID

NCT01844999

Original source

ClinicalTrials.gov

Source last updated

Jan 31, 2018

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT01844999

Title

Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks

Sponsor

Dana-Farber Cancer Institute

Status

COMPLETED

Phase

Condition raw

Prostate Cancer

Condition normalized

Prostate Cancer

Modality raw

behavioral intervention

Modality normalized

behavioral intervention

Target raw

Personal Patient Profile - Prostate (P3P), Standard prostate cancer information websites

Target normalized

Personal Patient Profile - Prostate (P3P), Standard prostate cancer information websites

Interventions

Personal Patient Profile - Prostate (P3P), Standard prostate cancer information websites

Public preview

Source record

The purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how to manage early stage prostate cancer.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT01844999

Status

COMPLETED

Phase

Sponsor

Dana-Farber Cancer Institute

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedJan 31, 2018

Internal syncJun 11, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01844999

Indication

Prostate Cancer

Modality

behavioral intervention

Target

Personal Patient Profile - Prostate (P3P), Standard prostate cancer information websites

Intervention

Personal Patient Profile - Prostate (P3P), Standard prostate cancer information websites

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.